Van Epps HL (2006) Bringing order to early B cell chaos. J Exp Med 203(6):1389–1389
(1984) Nomenclature for clusters of differentiation (CD) of antigens defined on human leukocyte populations. IUIS-WHO Nomenclature Subcommittee. Bull World Health Organ 62(5):809–15
Roussel M, Greenplate AR, Irish JM (2016) Dissecting complex cellular systems with high dimensional single cell mass cytometry. In: Montgomery RR, Bucala R (eds) Experimental Approaches for the Investigation of Innate Immunity. World Sci pp, 15–26. https://doi.org/10.1142/9789814678735_0002
DuPage M, Bluestone JA (2016) Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. Nat Rev Immunol 16(3):149–163
Ottoboni L, Merlini A, Martino G (2017) Neural stem cell plasticity: advantages in therapy for the injured central nervous system. Front Cell Dev Biol 5:52
Shen S, Clairambault J (2020) Cell plasticity in cancer cell populations. F1000Res 9:635
Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9):6425–6440
Irish JM, Kotecha N, Nolan GP (2006) Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat Rev Cancer 6(2):146–155
Mistry AM, Greenplate AR, Ihrie RA, Irish JM (2019) Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors. FEBS J 286(8):1523–1539
Kotliar D, Veres A, Nagy MA, Tabrizi S, Hodis E, Melton DA, Sabeti PC (2019) Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq. 8:e43803. https://doi.org/10.7554/eLife.43803
Mincarelli L, Lister A, Lipscombe J, Macaulay IC (2018) Defining cell identity with single-cell omics. Proteomics 18(18):1700312
Baslan T, Hicks J (2017) Unravelling biology and shifting paradigms in cancer with single-cell sequencing. Nat Rev Cancer 17(9):557–569
Flitsch LJ, Laupman KE, Brustle O (2020) Transcription factor-based fate specification and forward programming for neural regeneration. Front Cell Neurosci 14:121
Miyamoto T, Akashi K (2005) Lineage promiscuous expression of transcription factors in normal hematopoiesis. Int J Hematol 81(5):361–367
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105–111
Van Meter ME, Diaz-Flores E, Archard JA, Passegue E, Irish JM, Kotecha N, Nolan GP, Shannon K, Braun BS (2007) K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells. Blood 109(9):3945–3952
Bhaduri A, Di Lullo E, Jung D, Müller S, Crouch EE, Espinosa CS, Ozawa T, Alvarado B, Spatazza J, Cadwell CR, Wilkins G, Velmeshev D, Liu SJ, Malatesta M, Andrews MG, Mostajo-Radji MA, Huang EJ, Nowakowski TJ, Lim DA, Diaz A, Raleigh DR, Kriegstein AR (2020) Outer radial glia-like cancer stem cells contribute to heterogeneity of glioblastoma. Cell Stem Cell 26(1):48-63.e6
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432(7015):396–401
Torre-Healy LA, Berezovsky A, Lathia JD (2017) Isolation, characterization, and expansion of cancer stem cells. Methods Mol Biol 1553:133–143
Berezovsky AD, Poisson LM, Cherba D, Webb CP, Transou AD, Lemke NW, Hong X, Hasselbach LA, Irtenkauf SM, Mikkelsen T, deCarvalho AC (2014) Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation. Neoplasia 16(3):193–206, 206.e19–25
Stevanovic M, Kovacevic-Grujicic N, Mojsin M, Milivojevic M, Drakulic D (2021) SOX transcription factors and glioma stem cells: choosing between stemness and differentiation. World J Stem Cells 13(10):1417–1445
Zhang M, Song T, Yang L, Chen R, Wu L, Yang Z, Fang J (2008) Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27(1):85
Howard BM, Gursel DB, Bleau AM, Beyene RT, Holland EC, Boockvar JA (2010) EGFR signaling is differentially activated in patient-derived glioblastoma stem cells. J Exp Ther Oncol 8(3):247–260
Yamamuro S, Okamoto Y, Sano E, Ochiai Y, Ogino A, Ohta T, Hara H, Ueda T, Nakayama T, Yoshino A, Katayama Y (2015) Characterization of glioma stem-like cells from human glioblastomas. Int J Oncol 47(1):91–96
Leelatian N, Sinnaeve J, Mistry AM, Barone SM, Brockman AA, Diggins KE, Greenplate AR, Weaver KD, Thompson RC, Chambless LB, Mobley BC, Ihrie RA, Irish JM (2020) Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells. Elife 9:e56879. https://doi.org/10.7554/eLife.56879
Diggins KE, Greenplate AR, Leelatian N, Wogsland CE, Irish JM (2017) Characterizing cell subsets using marker enrichment modeling. Nat Methods 14(3):275–278
Kramer KJ, Wilfong EM, Voss K, Barone SM, Shiakolas AR, Raju N, Roe CE, Suryadevara N, Walker LM, Wall SC, Paulo A, Schaefer S, Dahunsi D, Westlake CS, Crowe JE Jr, Carnahan RH, Rathmell JC, Bonami RH, Georgiev IS, Irish JM (2022) Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine. Nat Commun 13(1):3466
Visvader JE, Lindeman GJ (2012) Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10(6):717–728
Dirks PB (2008) Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells. Philos Trans R Soc Lond B Biol Sci 363(1489):139–152
Wang JCY, Dick JE (2005) Cancer stem cells: lessons from leukemia. Trends Cell Biol 15(9):494–501
Rushing G, Ihrie RA (2016) Neural stem cell heterogeneity through time and space in the ventricular-subventricular zone. Front Biol 11(4):261–284
Yuan SH, Martin J, Elia J, Flippin J, Paramban RI, Hefferan MP, Vidal JG, Mu Y, Killian RL, Israel MA, Emre N, Marsala S, Marsala M, Gage FH, Goldstein LSB, Carson CT (2011) Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 6(3):e17540
Tang Y, Yu P, Cheng L (2017) Current progress in the derivation and therapeutic application of neural stem cells. Cell Death Dis 8(10):e3108–e3108
Glauche I, Marr C (2021) Mechanistic models of blood cell fate decisions in the era of single-cell data. Curr Opin Syst Biol 28:100355
Wognum AW, Eaves AC, Thomas TE (2003) Identification and isolation of hematopoietic stem cells. Arch Med Res 34(6):461–475
Zanjani ED, Almeida-Porada G, Ascensao JL, Mackintosh FR, Flake AW (2009) Transplantation of hematopoietic stem cells in utero. Stem Cells 15(S2):79–93
Sieburg HB, Cho RH, Dykstra B, Uchida N, Eaves CJ, Muller-Sieburg CE (2006) The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets. Blood 107(6):2311–2316
Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S (2010) Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 70(1):68–77
Xu X, Pan M, Jin T (2021) How Phagocytes acquired the capability of hunting and removing pathogens from a human body: lessons learned from chemotaxis and phagocytosis of Dictyostelium discoideum (review). Front Cell Dev Biol 9:724940
Kalina T, Fišer K, Pérez-Andrés M, Kuzílková D, Cuenca M, Bartol SJW, Blanco E, Engel P, van Zelm MC (2019) CD maps-dynamic profiling of CD1-CD100 surface expression on human leukocyte and lymphocyte subsets. Front Immunol 10:2434
Altin JG, Sloan EK (1997) The role of CD45 and CD45-associated molecules in T cell activation. Immunol Cell Biol 75(5):430–445
Yang H, Parkhouse RME, Wileman T (2005) Monoclonal antibodies that identify the CD3 molecules expressed specifically at the surface of porcine gammadelta-T cells. Immunology 115(2):189–196
Rudensky AY (2011) Regulatory T cells and Foxp 3. Immunol Rev 241(1):260–268
Desouki MM, Post GR, Cherry D, Lazarchick J (2010) PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Clin Med Res 8(2):84–88
Horcher M, Souabni A, Busslinger M (2001) Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14(6):779–790
Basso K, Dalla-Favera R (2012) Roles of BCL6 in normal and transformed germinal center B cells. Immunol Rev 247(1):172–183
Nutt SL, Fairfax KA, Kallies A (2007) BLIMP1 guides the fate of effector B and T cells. Nat Rev Immunol 7(12):923–927
Heyworth C (2002) Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO J 21(14):3770–3781
留言 (0)